TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
BWT Pharma & Biotech AB
Closing information (x1000 EUR)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
43,709
|
29,864
|
19,858 |
Financial expenses |
1
|
4
![]() |
4 |
Earnings before taxes |
7,018
|
4,335
|
2,385 |
EBITDA |
6,870
|
4,366
|
2,432 |
Total assets |
32,049
|
18,201
|
13,982 |
Current assets |
31,912
|
18,066
|
13,819 |
Current liabilities |
23,329
|
12,497
|
8,289 |
Equity capital |
8,542
|
4,782
|
3,447 |
- share capital |
45
![]() |
45
|
49 |
Employees (average) |
48
|
42
|
37 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
26.7%
|
26.3%
|
24.7% |
Turnover per employee |
911
|
711
|
537 |
Profit as a percentage of turnover |
16.1%
|
14.5%
|
12.0% |
Return on assets (ROA) |
21.9%
|
23.8%
|
17.1% |
Current ratio |
136.8%
|
144.6%
|
166.7% |
Return on equity (ROE) |
82.2%
|
90.7%
|
69.2% |
Change turnover |
13,757
|
11,615
|
-68 |
Change turnover % |
46%
|
64%
|
0% |
Chg. No. of employees |
6
|
5
|
9 |
Chg. No. of employees % |
14%
![]() |
14%
|
32% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.